L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3323
ETF rank
A$48.47 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
A$22.28
Share price
0.22%
Change (1 day)
10.44%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of November 2026: 0.49%